Clinical Trials Sponsored by Cankado Service GmbH

Total 164 results

Cankado GmbH

Recruiting

One Million Cancer Treatment Months (OMCAT)

Cancer

Germany
Cankado GmbH

Completed

Patients' Guidance With Onco-Coaching and CANKADO on Systemic Chemotherapy for Metastatic Colorectal Cancer (POSCA)

Metastatic Colorectal Cancer

Germany
Cankado GmbH

Completed

eHealth for the Elderly (My-eStEPs)

Multiple Myeloma

Germany
Cankado GmbH
Amgen

Completed

Health Economy Register (GeRA)

Breast Neoplasms

Germany
AIO-Studien-gGmbH
Servier Deutschland GmbH; Crolll Gmbh

Active, not recruiting

2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy (PREDICT)

Metastatic Pancreatic Cancer | Locally Advanced Pancreatic Cancer

Germany
Ced Service GmbH

Recruiting

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease (RUN-CD)

Crohn Disease

Germany
Ced Service GmbH

Not yet recruiting

TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners (TARGET)

Crohn Disease | Ulcerative Colitis | Indeterminate Colitis
Ced Service GmbH

Recruiting

Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany (VEDOibdI)

Inflammatory Bowel Diseases | Treatment

Germany
AIO-Studien-gGmbH
Amgen; WiSP Wissenschaftlicher Service Pharma GmbH

Completed

ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction (NEOPECX)

Stomach Neoplasms | Gastroesophageal Junction Neoplasms

Germany
Ced Service GmbH
Pfizer

Terminated

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany (TOFA-UC)

Colitis, Ulcerative | Bowel Disease | Bowel Diseases, Inflammatory | Biologics | Chronic Inflammatory Small Bowel Disease | Tofacitiniib | CED

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Mundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbH

Completed

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
ClinAssess GmbH

Unknown

Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer (PROVE)

Ovarian Cancer

Germany
WiSP Wissenschaftlicher Service Pharma GmbH

Completed

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy (DSMM-II)

Multiple Myeloma
Dolorgiet GmbH & Co. KG
d.s.h. statistical services GmbH; CenTrial GmbH

Completed

Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis

Actinic Keratosis Olsen Grade I/II

Germany
Cardionovum GmbH
CliPS Service; OPIS srl

Terminated

APERTO CVS PMCF Study (APERTO CVS)

Restenosis | Stenosis | Dialysis; Complications | Central Vein Obstruction

Germany
Pierre Fabre Pharma GmbH
DocCheck Medical Services GmbH

Completed

JAVLOR® Online Non-Interventional Trial (JONAS-1)

Transitional Cell Carcinoma

Germany
Servier Deutschland GmbH
iOMEDICO AG

Completed

Trifluridin/tipirACil in meTastatIc Colorectal Cancer (TACTIC)

Metastatic Colorectal Cancer

Germany
Ludwig-Maximilians - University of Munich
Cankado GmbH

Completed

Monitoring of Palliative Care Needs in Specialized Palliative Home Care Using the Electronic Version of the Integrated Palliative Care Outcome Scale (Palli-MONITOR)

Advanced Disease

Germany
Ludwig-Maximilians - University of Munich
Cankado GmbH

Recruiting

Patient-centered Nutrition Care II: An E-health Supported Symptom Based Nutrition Intervention (PaCC II)

Quality of Life | Nutritional Status | Psychological Distress | Weight Change, Body

Germany
SocraTec R&D GmbH
SocraMetrics GmbH; Glatt Pharmaceutical Services GmbH & Co. KG

Completed

Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration

Comparative Bioavailability

Germany
Desitin Arzneimittel GmbH
BioPharma Services, Inc

Completed

Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.

Food-drug Interaction

Canada
Desitin Arzneimittel GmbH
BioPharma Services, Inc

Completed

Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets

Multiple Drug Use

Canada
Desitin Arzneimittel GmbH
BioPharma Services, Inc

Completed

Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions

Fasting

Canada
Biogen
AMS Advanced Medical Services GmbH

Completed

A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis (PERFECT)

Multiple Sclerosis, Relapsing-Remitting

Germany
Biotest
AMS Advanced Medical Services GmbH

Completed

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant (ZEUS)

Hepatitis B

Spain, United Kingdom, France, Italy
Cytonet GmbH & Co. KG
CRS Clinical Research Services Mannheim GmbH

Completed

Study in Healthy Subjects, Patients With Urea Cycle Disorders (UCD) and Carriers of UCD Mutations to Evaluate Urea Cycle Function

Urea Cycle Disorders

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Unknown

Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III) (NEO-RIT)

Rectal Cancer

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Terminated

PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer (PURO)

Urinary Bladder Cancer

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Suspended

Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Germany
NonWoTecc Medical GmbH
MDT Medical Device Testing GmbH

Terminated

Clinical Pilot-Study of ProEndoTecc Vascular Grafts as Superficial Femoral Artery Bypass / Interponate

Peripheral Arterial Disease | Peripheral Vascular Disease

Germany
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Active, not recruiting

Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD

Limbal Stem Cell Deficiency

United States, Germany
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of CVU

Skin Ulcer Venous Stasis Chronic

Germany
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Terminated

Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From Ulcers

Skin Ulcer Venous Stasis Chronic

Germany
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Terminated

Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD

Peripheral Arterial Occlusive Disease

Germany, Austria, Czechia, Poland, United Kingdom
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Recessive Dystrophic Epidermolysis Bullosa

United States, Austria, France, Germany, United Kingdom
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans"

Diabetic Neuropathic Ulcer

Germany
Silence Therapeutics GmbH
FGK Clinical Research GmbH; Granzer Regulatory Consulting & Services

Completed

Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) (Atu027-I-02)

Carcinoma, Pancreatic Ductal

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
proDERM Institut für Angewandte Dermatologische Forschung GmbH; Bremer Pharmacovigilance... and other collaborators

Completed

Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol

Vulvovaginal Atrophy

Germany, Switzerland
Dr. August Wolff GmbH & Co. KG Arzneimittel
FGK Clinical Research GmbH; Nuvisan GmbH; Charles River Biopharmaceutical Services...

Completed

Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Ludwig-Maximilians - University of Munich; Chugai Pharma GmbH

Completed

Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy (CU01)

Hodgkin's Disease | Non-Hodgkin Lymphomas | Multiple Myelomas
Palleos Healthcare GmbH
Roche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP

Completed

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients (TP-II)

Breast Neoplasms

Germany
AIO-Studien-gGmbH
Servier; Institut für Klinisch-Onkologische Forschung der Krankenhaus Nordwest...

Active, not recruiting

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer (NIFE)

Biliary Tract Cancer | Extrahepatic Bile Duct Carcinoma | Non-Resectable Hepatocellular Carcinoma | Adenocarcinoma Metastatic | Adenocarcinoma of the Biliary Tract | Adenocarinoma Locally Advanced | Intrahepatic Bile Duct Carcinoma

Germany
Pieris Pharmaceuticals GmbH
FGK Clinical Research GmbH; Nuvisan Pharma Services; EUROCALIN Consortium

Completed

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRS-080

Healthy

Germany
AvenCell Europe GmbH
GCP-Service International Ltd. & Co. KG

Terminated

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Transitional Cell Carcinoma | Prostate Cancer | Non-small Cell Lung Cancer | Renal Cancer

Germany
AvenCell Europe GmbH
GCP-Service International Ltd. & Co. KG

Terminated

Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Relapsed AML | Refractory AML

Germany
Oxo Chemie GmbH

Completed

A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection

HIV Infections

United States
AIO-Studien-gGmbH
Servier

Completed

Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies (NALIRICC)

Cholangiocarcinoma Non-resectable | Cholangiocarcinoma of the Gallbladder | Cholangiocarcinoma Metastatic | Cholangiocarcinoma Advanced

Germany
University of Malaga
BSN Medical GmbH; Andalusian Health Service

Unknown

Effectiveness of a Hydrophobic Dressing for Microorganisms' Colonization and Infection Control of Vascular Ulcers (CUCO-UV)

Bacterial Infections | Venous Leg Ulcer | Chronic Ulcer of Skin of Lower Limb Nos

Spain
Oxo Chemie GmbH

Completed

A Study of WF 10 IV Solution in Patients With Advanced HIV Disease

HIV Infections

United States
Dr. August Wolff GmbH & Co. KG Arzneimittel
proDERM Institut für Angewandte Dermatologische Forschung GmbH; Bremer Pharmacovigilance...

Completed

Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

Vulvovaginal Atrophy

Germany

Clinical Trials Sponsored by Cankado Service GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations